Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Breast Cancer: Targets and Therapy Volume 9, 2017 - Issue

Submit an article Journal homepage

Open access

197

Views

CrossRef citations to date

Altmetric

Review

Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib

Dumessa Edessa1 Department of Pharmacy PracticeCorrespondence[email protected]

Mekonnen Sisay2 Department of Pharmacology and Toxicology, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Oromia, Ethiopia

Pages 567-579 | Published online: 06 Dec 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Busra Demir Cetinkaya & Cigir Biray Avci. (2022) Molecular perspective on targeted therapy in breast cancer: a review of current status. Medical Oncology 39:10.
Crossref

Sanjana Reddy, Zineb Barkhane, Jalal Elmadi, Lakshmi Satish Kumar, Lakshmi Sree Pugalenthi & Mahlika Ahmad. (2022) Cyclin-Dependent Kinase 4 and 6 Inhibitors: A Quantum Leap in the Treatment of Advanced Breast Cancers. Cureus.
Crossref

Kaitlin Rascon, Goran Flajc, Carmine De Angelis, Xinli Liu, Meghana V. Trivedi & Ekim Ekinci. (2018) Ribociclib in HR+/HER2− Advanced or Metastatic Breast Cancer Patients. Annals of Pharmacotherapy 53:5, pages 501-509.
Crossref

Ayesha Aftab, Shaheen Shahzad, Hafiz Muhammad Jafar Hussain, Ranjha Khan, Samra Irum & Sobia Tabassum. (2018) CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis. Breast Cancer 26:1, pages 11-28.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references